|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
|
5SC2CA138179-02
|
|
AKALA, EMMANUEL
|
HOWARD UNIVERSITY
|
|
Biosynthesis of Taxol Precursors in Transgenic Moss
|
1R15CA139416-01
|
$218,250
|
Anterola, Aldwin
|
SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
|
|
SPORE in Breast Cancer
|
5P50CA098131-07
|
$2,300,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-23
|
$2,304,698
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-06
|
$346,857
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)
|
1U54CA143803-01
|
$3,008,880
|
AUSTIN, ROBERT
|
PRINCETON UNIVERSITY
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING
|
2R01CA101850-05A1
|
$271,181
|
Bae, You
|
UNIVERSITY OF UTAH
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-19
|
$687,330
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-05
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
3R01CA119409-04S1
|
$50,000
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
5R01CA119409-05
|
$492,995
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-09S1
|
$57,442
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-10S1
|
$141,526
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-10
|
$2,001,032
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$109,331
|
Bates, Susan
|
CCR (NCI)
|
|
Identification of druggable targets for triple-negative breast cancer
|
1F32CA138106-01
|
$50,054
|
Bauer, Joshua
|
VANDERBILT UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
5U10CA035101-24
|
$865,544
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Gynecologic Oncology Group Statistical and Data Center
|
5U10CA037517-25
|
$4,762,145
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer and Leukemia Group B - The Ohio State University
|
2U10CA077658-12
|
$494,501
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
|
2R01CA098706-06A1
|
$286,978
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$859,245
|
Brechbiel, Martin
|
CCR (NCI)
|
|
North Central Cancer Treatment Group
|
5U10CA025224-30
|
$5,852,515
|
BUCKNER, JAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Cancer and Leukemia Group B
|
2U10CA032291-28
|
$413,820
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-26
|
$1,278,666
|
Bury, Martin
|
SPECTRUM HEALTH HOSPITALS
|
|
Cancer Center Support Grant
|
3P30CA046934-22S1
|
$146,023
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-22S2
|
$85,992
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
5P30CA046934-22
|
$4,497,135
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Tubulin Mutations and Paclitaxel Resistance
|
5R01CA085935-09
|
$263,242
|
CABRAL, FERNANDO
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
2U10CA101140-07
|
$861,611
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
SPORE in Lung Cancer
|
5P50CA090949-08
|
$2,300,000
|
CARBONE, DAVID
|
VANDERBILT UNIVERSITY
|
|
Molecular Signatures of Lung Cancer
|
5U01CA114771-05
|
|
CARBONE, DAVID
|
VANDERBILT UNIVERSITY
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
2U10CA045560-21
|
$561,390
|
CAROLLA, ROBERT
|
OZARK HEALTH VENTURES, LLC
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-05
|
$252,236
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-04
|
$67,765
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer
|
5R43CA132841-02
|
$94,729
|
CHENCHIK, ALEX
|
CELLECTA, INC.
|
|
HAWAII MINORITY-BASED CCOP
|
3U10CA063844-16S1
|
$100,000
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
HAWAII MINORITY-BASED CCOP
|
5U10CA063844-16
|
$699,073
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
In Vivo Cancer Therapy Monitoring with Diffuse Optical Methods
|
5K99CA126187-02
|
$83,233
|
CHOE, REGINE
|
UNIVERSITY OF PENNSYLVANIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|